Janux Therapeutics Inc.

NASDAQ: JANX · Real-Time Price · USD
25.04
0.07 (0.28%)
At close: Aug 15, 2025, 3:59 PM
25.11
0.30%
After-hours: Aug 15, 2025, 04:34 PM EDT

Janux Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-68.99M -58.29M -63.06M -32.67M
Depreciation & Amortization
2.06M 1.96M 841K 113K
Stock-Based Compensation
33.02M 20M 17.2M 6.91M
Other Working Capital
-899K -6.83M 4.57M -2.13M
Other Non-Cash Items
-10.59M -7.69M -2.18M -169K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
685K -6.55M 4.28M 8.84M
Operating Cash Flow
-43.81M -50.58M -42.92M -16.98M
Capital Expenditures
-359K -1.85M -6.45M -1.48M
Cash Acquisitions
n/a n/a -64.71M 339.48M
Purchase of Investments
-470.58M -317.34M -294.39M -473.63M
Sales Maturities Of Investments
212.91M 278M 359.1M 134.15M
Other Investing Acitivies
n/a n/a 64.71M -339.48M
Investing Cash Flow
-258.02M -41.19M 58.27M -340.96M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
14.97M 3.02M n/a 1.81M
Financial Cash Flow
713.24M 59.55M 500K 386.52M
Net Cash Flow
411.4M -32.22M 15.84M 28.59M
Free Cash Flow
-44.17M -52.42M -49.37M -18.46M